Pluripotent stem cells act as an excellent cell source for disease therapy because of its specific characteristics of self-renewal and differentiation. Pluripotent stem cells are heterogeneous, consisting of naive stem cells as well as primed epiblast stem cells. However, the strategies and mechanisms of maintaining naive pluripotent stem cells remain unclear. In this study, we found that folic acid (FA) sustained mouse embryonic stem cell (ESC) pluripotency and enabled long-term maintenance of the naive state of ESCs under CHIR99021 conditions. Mechanistic experiments showed that STAT3 pathway partially mediated the effect of FA after which the interaction between STAT3 and importin α5 was enhanced. Meanwhile, MEK/ERK signaling also acted downstream of FA in maintaining ESC pluripotency. Furthermore, FA significantly promoted mouse somatic cell reprogramming. Overall, our study identified an effective chemical condition for maintaining homogeneous ESCs and highlighted the important roles of LIF/STAT3 and MEK/ERK signaling in naive ESC pluripotency.
Get full access to this article
View all access options for this article.
References
1.
DuscherD, BarreraJ, WongVW, MaanZN, WhittamAJ, JanuszykM and GurtnerGC. (2015). Stem cells in wound healing: the future of regenerative medicine? A mini-review. Gerontology, 62:216–225.
2.
GuintoG, ZepedaE and LondonoD. (2015). Cell therapy: engineering and manufacture of pluripotent cells. World Neurosurg, 84:1209–1210.
3.
MeadB, BerryM, LoganA, ScottRA, LeadbeaterW and SchevenBA. (2015). Stem cell treatment of degenerative eye disease. Stem Cell Res, 14:243–257.
4.
NowakowskiA, WalczakP, JanowskiM and LukomskaB. (2015). Genetic engineering of mesenchymal stem cells for regenerative medicine. Stem Cells Dev, 24:2219–2242.
5.
CoresJ, CaranasosTG and ChengK. (2015). Magnetically targeted stem cell delivery for regenerative medicine. J Funct Biomater, 6:526–546.
6.
MeganJM, AnnaEM, CarmelMOB, AlanOT, MartinFP and PeterSM. (2000). Isolation of pluripotent embryonic stem cells from reprogrammed adult mouse somatic cell nuclei. Curr Biol, 10:989–992.
7.
TakahashiK and YamanakaS. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126:663–676.
8.
KimK, ChoiH, ChoiS and DoJ. (2011). Reprogrammed pluripotent stem cells from somatic cells. Int J Stem Cells, 4:1–8.
9.
Iglesias-GarciaO, PelachoB and ProsperF. (2013). Induced pluripotent stem cells as a new strategy for cardiac regeneration and disease modeling. J Mol Cell Cardiol, 62:43–50.
10.
PingpingH, YanqinL, XuZ, ChunL, JingyangG, HonggangL, TingZ, JunqingY, WeifengY, et al. (2013). Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science, 341:651–654.
11.
KangPJ, MoonJ-H, YoonBS, HyeonS, JunEK, ParkG, YunW, ParkJ, ParkM, et al. (2014). Reprogramming of mouse somatic cells into pluripotent stem-like cells using a combination of small molecules. Biomaterials, 35:7336–7345.
12.
LuF and ZhangY. (2015). Cell totipotency: molecular features, induction, and maintenance. Natl Sci Rev, 2:217–225.
13.
GrafU, CasanovaEA and CinelliP. (2011). The role of the Leukemia Inhibitory Factor (LIF)—pathway in derivation and maintenance of murine pluripotent stem cells. Genes (Basel), 2:280–297.
14.
OronE and IvanovaN. (2012). Cell fate regulation in early mammalian development. Phys Biol, 9:045002.
15.
BoylesAL, BallardJL, GormanEB, McConnaugheyDR, CabreraRM, WilcoxAJ, LieRT and FinnellRH. (2011). Association between inhibited binding of folic acid to folate receptor alpha in maternal serum and folate-related birth defects in Norway. Hum Reprod, 26:2232–2238.
16.
BoylesAL, BillupsAV, DeakKL, SiegelDG, MehltretterL, SliferSH, BassukAG, KesslerJA, ReedMC, et al. (2006). Neural tube defects and folate pathway genes: family-based association tests of gene–gene and gene–environment interactions. Environ Health Perspect, 114:1547–1552.
17.
IchiS, NakazakiH, BoshnjakuV, SinghRM, Mania-FarnellB, XiG, McLoneDG, TomitaT and MayanilCS. (2012). Fetal neural tube stem cells from Pax3 mutant mice proliferate, differentiate, and form synaptic connections when stimulated with folic acid. Stem Cells Dev, 21:321–330.
18.
HiraiH, KarianP and KikyoN. (2011). Regulation of embryonic stem cell self-renewal and pluripotency by leukaemia inhibitory factor. Biochem J, 438:11–23.
19.
NiwaH, OgawaK, ShimosatoD and AdachiK. (2009). A parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells. Nature, 460:118–122.
20.
MarksH, KalkanT, MenafraR, DenissovS, JonesK, HofemeisterH, NicholsJ, KranzA, StewartAF, SmithA and StunnenbergHG. (2012). The transcriptional and epigenomic foundations of ground state pluripotency. Cell, 149:590–604.
21.
GalonskaC, ZillerMJ, KarnikR and MeissnerA. (2015). Ground state conditions induce rapid reorganization of core pluripotency factor binding before global epigenetic reprogramming. Cell Stem Cell, 17:462–470.
22.
SilvaJ, BarrandonO, NicholsJ, KawaguchiJ, TheunissenTW and SmithA. (2008). Promotion of reprogramming to ground state pluripotency by signal inhibition. PLoS Biol, 6:e253.
23.
WeiT, ChenW, WangX, ZhangM, ChenJ, ZhuS, ChenL, YangD, WangG, et al. (2015). An HDAC2-TET1 switch at distinct chromatin regions significantly promotes the maturation of pre-iPS to iPS cells. Nucleic Acids Res, 43:5409–5422.
24.
BoshnjakuV, ShimKW, TsurubuchiT, IchiS, SzanyEV, XiG, Mania-FarnellB, McLoneDG, TomitaT and MayanilCS. (2012). Nuclear localization of folate receptor alpha: a new role as a transcription factor. Sci Rep, 2:980.
25.
MohantyV, ShahA, AllenderE, SiddiquiMR, MonickS, IchiS, Mania-FarnellB, GM D, TomitaT and MayanilCS. (2016). Folate receptor alpha upregulates Oct4, Sox2 and Klf4 and downregulates miR-138 and miR-let-7 in cranial neural crest cells. Stem Cells. DOI:10.1002/stem.2421
26.
LeeJT and BartolomeiMS. (2013). X-inactivation, imprinting, and long noncoding RNAs in health and disease. Cell, 152:1308–1323.
27.
ChowJ and HeardE. (2009). X inactivation and the complexities of silencing a sex chromosome. Curr Opin Cell Biol, 21:359–366.
28.
WernigM, MeissnerA, ForemanR, BrambrinkT, KuM, HochedlingerK, BernsteinBE and JaenischR. (2007). In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature, 448:318–324.
29.
HamiltonWB, KajiK and KunathT. (2013). ERK2 suppresses self-renewal capacity of embryonic stem cells, but is not required for multi-lineage commitment. PLoS One, 8:e60907.
30.
LannerF and RossantJ. (2010). The role of FGF/Erk signaling in pluripotent cells. Development, 137:3351–3360.
31.
KunathT, Saba-El-LeilMK, AlmousailleakhM, WrayJ, MelocheS and SmithA. (2007). FGF stimulation of the Erk1/2 signalling cascade triggers transition of pluripotent embryonic stem cells from self-renewal to lineage commitment. Development, 134:2895–2902.
32.
NicholsJ, SilvaJ, RoodeM and SmithA. (2009). Suppression of Erk signalling promotes ground state pluripotency in the mouse embryo. Development, 136:3215–3222.
33.
TangY, LuoY, JiangZ, MaY, LinCJ, KimC, CarterMG, AmanoT, ParkJ, KishS and TianXC. (2012). Jak/Stat3 signaling promotes somatic cell reprogramming by epigenetic regulation. Stem Cells, 30:2645–2656.
34.
TaiCI and YingQL. (2013). Gbx2, a LIF/Stat3 target, promotes reprogramming to and retention of the pluripotent ground state. J Cell Sci, 126:1093–1098.
35.
WrayJ, KalkanT and SmithAG. (2010). The ground state of pluripotency. Biochem Soc Trans, 38:1027–1032.
36.
MartelloG, BertoneP and SmithA. (2013). Identification of the missing pluripotency mediator downstream of leukaemia inhibitory factor. EMBO J, 32:2561–2574.
37.
ChenX, XuH, YuanP, FangF, HussM, VegaVB, WongE, OrlovYL, ZhangW, et al. (2008). Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell, 133:1106–1117.
38.
SinghAM, BechardM, SmithK and DaltonS. (2012). Reconciling the different roles of Gsk3beta in “naive” and “primed” pluripotent stem cells. Cell Cycle, 11:2991–2996.
39.
NiwaH, BurdonT, ChamberI and SmithA. (1998). Self renewal of pluripotent embryonic stem cells is mediated via activation. Genes Dev, 12:2048–2060.
40.
OnishiK and ZandstraPW. (2015). LIF signaling in stem cells and development. Development, 142:2230–2236.
41.
YeS, LiP, TongC and YingQL. (2013). Embryonic stem cell self-renewal pathways converge on the transcription factor Tfcp2l1. EMBO J, 32:2548–2560.
42.
KotzkaJ, LehrS, RothG, AvciH, KnebelB and Muller-WielandD. (2004). Insulin-activated Erk-mitogen-activated protein kinases phosphorylate sterol regulatory element-binding Protein-2 at serine residues 432 and 455 in vivo. J Biol Chem, 279:22404–22411.
43.
HartmanME, DaiDF and LaflammeMA. (2015). Human pluripotent stem cells: prospects and challenges as a source of cardiomyocytes for in vitro modeling and cell-based cardiac repair. Adv Drug Deliv Rev, 96:3–7.
44.
NicholsJ and SmithA. (2009). Naive and primed pluripotent states. Cell Stem Cell, 4:487–492.
45.
FonsecaSA, CostasRM and PereiraLV. (2015). Searching for naive human pluripotent stem cells. World J Stem Cells, 7:649–656.
46.
DodsworthBT, FlynnR and CowleySA. (2015). The current state of naive human pluripotency. Stem Cells, 33:3081–3086.
47.
HuW-T, YanQ-Y, FangY, QiuZ-D and ZhangS-M. (2014). Transient folate deprivation in combination with small-molecule compounds facilitates the generation of somatic cell-derived pluripotent stem cells in mice. J Huazhong Univ Sci Technolog Med Sci, 34:151–156.
48.
KimJ, ChuJ, ShenX, WangJ and OrkinSH. (2008). An extended transcriptional network for pluripotency of embryonic stem cells. Cell, 132:1049–1061.
49.
PapatsenkoD, DarrH, KulakovskiyIvan V, WaghrayA, MakeevVJ, MacArthurBD and LemischkaIR. (2015). Single-cell analyses of ESCs reveal alternative pluripotent cell states and molecular mechanisms that control self-renewal. Stem Cell Reports, 5:207–220.
50.
ToyookaY, ShimosatoD, MurakamiK, TakahashiK and NiwaH. (2008). Identification and characterization of subpopulations in undifferentiated ES cell culture. Development, 135:909–918.
51.
van OostenAL, CostaY, SmithA and SilvaJC. (2012). JAK/STAT3 signalling is sufficient and dominant over antagonistic cues for the establishment of naive pluripotency. Nat Commun, 3:817.
52.
YangJ, van OostenAL, TheunissenTW, GuoG, SilvaJC and SmithA. (2010). Stat3 activation is limiting for reprogramming to ground state pluripotency. Cell Stem Cell, 7:319–328.
53.
GokeJ, ChanYS, YanJ, VingronM and NgHH. (2013). Genome-wide kinase-chromatin interactions reveal the regulatory network of ERK signaling in human embryonic stem cells. Mol Cell, 50:844–855.
54.
AntonyAC. (2007). In utero physiology: role of folic acid in nutrient delivery and fetal development. Am J Clin Nutr, 85:598S–603S.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
